SCHEMBL13745019

SCHEMBL13745019

CCN(CC)CCOc1cc(C)c(Cl)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
MCOLN3 Q8TDD5 1/20 0.47
BIRC5 O15392 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.42
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD3 P35462 1/20 0.41
HSP90AB1 P08238 2/20 0.40
KCNH2 Q12809 1/20 0.40
MAPT P10636 3/20 0.40
TSHR P16473 1/20 0.40
TP53 P04637 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP2C19 P33261 1/20 0.39
KDR P35968 1/20 0.39
CHRNA7 P36544 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13602317 0.87 KDM4E (0.53) KDM4EMCOLN3BIRC5SMN1; SMN2SIGMAR1
SCHEMBL13696489 0.83 KDM4E (0.49) KDM4EMCOLN3SMN1; SMN2ALDH1A1TDP1
SCHEMBL13648205 0.83 KDM4E (0.49) KDM4EMCOLN3BIRC5SMN1; SMN2SIGMAR1
SCHEMBL2564475 0.82 KDM4E (0.44) KDM4EBIRC5SMN1; SMN2SIGMAR1ALDH1A1
SCHEMBL1755246 0.80 MCOLN3 (0.56) KDM4EMCOLN3SMN1; SMN2ALDH1A1MAPT
SCHEMBL14421841 0.79 MCOLN3 (0.48) MCOLN3SMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL11207045 0.79 KDM4E (0.44) KDM4EBIRC5SMN1; SMN2SIGMAR1ALDH1A1
SCHEMBL31222300 0.77 MAPT (0.40) MCOLN3SMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL13648163 0.77 S1PR4 (0.44) KDM4EMCOLN3BIRC5SMN1; SMN2ALDH1A1
SCHEMBL7940396 0.77 HPGD (0.57) KDM4EBIRC5SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 4124/4885MCOLN3 3189/4885BIRC5 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.